866-997-4948(US-Canada Toll Free)

CerboMed GmbH - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 48 Pages


CerboMed GmbH (CerboMed) is a medical device company, based in Germany. The company researches, develops and manufactures technologies and products in the area of neuromodulation. It provides treatment for various neurological and psychiatric disorders. The company provides a new therapy for epilepsy and depression CerboMed also develops transcutaneous Vagus Nerve Stimulation (t-VNS). The company is financed by various venture capital companies which includes, Munich MIG AG, S-Refit AG Regensburg, medTECH Capital Fonds GmbH (mTCF) Erlangen. It was founded in the year 2005. CerboMed is headquartered in Erlangen, Germany.

This report is a source for data, analysis and actionable intelligence on the CerboMed GmbH portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4

Key Facts 5
CerboMed GmbH - Major Products and Services 6
CerboMed GmbH Pipeline Products by Equipment Type 7
CerboMed GmbH Pipeline Products by Development Stage 9
CerboMed GmbH Pipeline Products by Therapy Area 11
CerboMed GmbH Pipeline Products by Trial Phase 13
CerboMed GmbH Pipeline Products by Milestone Summary 15
NEMOS - Depression 17
NEMOS - Depression Product Status 17
NEMOS - Depression Product Description 17
NEMOS - Depression Clinical Trial 17
NEMOS - Depression Product Patent Details 19
NEMOS - Epilepsy 23
NEMOS - Epilepsy Product Status 23
NEMOS - Epilepsy Product Description 23
NEMOS - Epilepsy Product Milestone 23
NEMOS - Epilepsy Product Patent Details 24
NEMOS - Pain 27
NEMOS - Pain Product Status 27
NEMOS - Pain Product Description 27
NEMOS - Pain Product Milestone 27
NEMOS - Pain Clinical Trial 28
NEMOS - Pain Product Patent Details 29
NEMOS - Schizophrenia 33
NEMOS - Schizophrenia Product Status 33
NEMOS - Schizophrenia Product Description 33
NEMOS - Schizophrenia Clinical Trial 33
NEMOS - Schizophrenia Product Patent Details 35
NEMOS - Tinnitus 39
NEMOS - Tinnitus Product Status 39
NEMOS - Tinnitus Product Description 39
NEMOS - Tinnitus Clinical Trial 39
NEMOS - Tinnitus Product Patent Details 41
CerboMed GmbH - Key Competitors 44
CerboMed GmbH - Key Employees 45
CerboMed GmbH - Locations And Subsidiaries 46
Head Office 46
Recent Developments 47
CerboMed GmbH, Recent Developments 47
Feb 10, 2011: cerbomed Announces Advisory Board Appointments 47
Jan 27, 2011: cerbomed Appoints Christian Elger To Scientific Advisory Board 47

Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Table


CerboMed GmbH, Key Facts 1
CerboMed GmbH Key Pipeline Products by Equipment Type 1
CerboMed GmbH Key Pipeline Products by Therapy Area 1
CerboMed GmbH Key Pipeline Products by Development Stage 1
CerboMed GmbH Key Pipeline Products by Trial Phase 1
CerboMed GmbH, Key Facts 5
CerboMed GmbH, Major Products and Services 6
CerboMed GmbH Number of Pipeline Products by Equipment Type 7
CerboMed GmbH Pipeline Products by Equipment Type 8
CerboMed GmbH Number of Pipeline Products by Development Stage 9
CerboMed GmbH Pipeline Products by Development Stage 10
CerboMed GmbH Number of Pipeline Products by Therapy Area 11
CerboMed GmbH Pipeline Products by Therapy Area 12
CerboMed GmbH Number of Pipeline Products by Trial Phase 13
CerboMed GmbH Pipeline Products by Trial Phase 14
CerboMed GmbH Number of Pipeline Products By Milestone Summary 15
CerboMed GmbH Pipeline Products by Milestone Summary 16
NEMOS - Depression - Product Status 17
NEMOS - Depression - Product Description 17
NEMOS - Depression - Transcutaneous Non-invasive Stimulation of the Vagus Nerve for the Treatment of Difficult-to-treat Epilepsy - a Prospective Pilot Study Regarding Safety, Effectiveness and Clinical Performance 17
NEMOS - Depression - Patent Details1 19
NEMOS - Depression - Patent Details2 20
NEMOS - Depression - Patent Details3 20
NEMOS - Depression - Patent Details4 21
NEMOS - Depression - Patent Details5 22
NEMOS - Epilepsy - Product Status 23
NEMOS - Epilepsy - Product Description 23
NEMOS - Epilepsy - Product Milestone 23
NEMOS - Epilepsy - Patent Details1 24
NEMOS - Epilepsy - Patent Details2 24
NEMOS - Epilepsy - Patent Details3 25
NEMOS - Epilepsy - Patent Details4 25
NEMOS - Epilepsy - Patent Details5 26
NEMOS - Pain - Product Status 27
NEMOS - Pain - Product Description 27
NEMOS - Pain - Product Milestone 27
NEMOS - Pain - Controlled, Randomized Study of Pain Perception and Psychophysiological Reactions of the Autonomic Nervous System Under Transcutaneous, Electrical Stimulation of the Vagus Nerve in Healthy Volunteers 28
NEMOS - Pain - Patent Details1 29
NEMOS - Pain - Patent Details2 30
NEMOS - Pain - Patent Details3 31
NEMOS - Pain - Patent Details4 31
NEMOS - Pain - Patent Details5 32
NEMOS - Schizophrenia - Product Status 33
NEMOS - Schizophrenia - Product Description 33
NEMOS - Schizophrenia - Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia: a Randomized, Controlled, Double Blind, Two-armed Clinical Trial 33
NEMOS - Schizophrenia - Patent Details1 35
NEMOS - Schizophrenia - Patent Details2 36
NEMOS - Schizophrenia - Patent Details3 36
NEMOS - Schizophrenia - Patent Details4 37
NEMOS - Schizophrenia - Patent Details5 38
NEMOS - Tinnitus - Product Status 39
NEMOS - Tinnitus - Product Description 39
NEMOS - Tinnitus - The Treatment of Tinnitus With Transcutaneous Non-invasive Vagus Nerve stimulation-a Controlled Randomized Pilot Study Assessing Safety, Compatibility and Clinical Performance 39
NEMOS - Tinnitus - Patent Details1 41
NEMOS - Tinnitus - Patent Details2 41
NEMOS - Tinnitus - Patent Details3 42
NEMOS - Tinnitus - Patent Details4 42
NEMOS - Tinnitus - Patent Details5 43
CerboMed GmbH, Key Employees 45

List of Chart


CerboMed GmbH Pipeline Products by Equipment Type 7
CerboMed GmbH Pipeline Products by Development Stage 9
CerboMed GmbH Pipeline Products by Therapy Area 11
CerboMed GmbH Pipeline Products by Trial Phase 13
CerboMed GmbH Pipeline Products by Milestone Summary 15

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *